BALAXI PHARMACEUTICALS LIMITED (BALAXI) reported revenue of ₹80.68 Cr and net profit of ₹1.30 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from BALAXI PHARMACEUTICALS LIMITED’s filed results, 17 filed quarters and 8 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 6, 2026 · audited
| ₹ Cr | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82.8 | 86.4 | 86.6 | 80.7 | 66.0 | 54.7 | 60.8 | 59.8 | 65.6 | 77.4 | 73.3 | 76.3 | 70.7 | 56.2 | 72.5 | 70.7 | 80.7 | +14.1% |
| 69.0 | 71.6 | 71.3 | 67.9 | 57.1 | 44.0 | 47.1 | 46.4 | 55.5 | 66.8 | 69.3 | 63.7 | 66.6 | 55.0 | 69.5 | 70.6 | 76.0 | +14.2% | |
| Operating profit | 13.7 | 14.8 | 15.3 | 12.7 | 8.84 | 10.8 | 13.7 | 13.5 | 10.1 | 10.6 | 3.99 | 12.5 | 4.15 | 1.17 | 3.09 | 0.12 | 4.66 | +12.4% |
| OPM % | 16.6% | 17.1% | 17.7% | 15.8% | 13.4% | 19.7% | 22.5% | 22.5% | 15.4% | 13.7% | 5.4% | 16.5% | 5.9% | 2.1% | 4.3% | 0.2% | 5.8% | -0.1 pp |
| Other income | 3.28 | 4.14 | -4.57 | -0.22 | -1.01 | 0.28 | -0.13 | -1.79 | -1.85 | -4.11 | 3.94 | -1.69 | -1.78 | 1.59 | 0.10 | 2.92 | -0.99 | n/m |
| Interest | 0.20 | 0.02 | 0.01 | 0.27 | 0.29 | 0.37 | 0.41 | 0.61 | 0.37 | 0.45 | 1.38 | 0.73 | 1.01 | 0.89 | 1.02 | 0.99 | 0.73 | -27.2% |
| Depreciation | 0.19 | 0.19 | 0.19 | 1.19 | 0.29 | 0.66 | 0.48 | 0.67 | 0.49 | 0.46 | 0.48 | 0.46 | 0.46 | 0.48 | 0.56 | 0.65 | 0.85 | +83.5% |
| Profit before tax | 16.6 | 18.7 | 10.5 | 11.1 | -39.4 | 15.7 | 14.3 | 11.5 | 7.37 | 5.56 | 6.07 | 9.66 | 0.90 | 1.38 | 1.61 | 1.40 | 2.09 | +131.3% |
| Tax % | 15.0% | 17.1% | 21.8% | 26.8% | n/a (loss) | 7.9% | 4.8% | 4.9% | 12.1% | 17.5% | 11.6% | 10.6% | 67.9% | 84.8% | 81.1% | 56.3% | 37.9% | -30.0 pp |
| Net profit | 14.1 | 15.5 | 8.23 | 8.10 | -41.3 | 14.4 | 13.6 | 10.9 | 6.48 | 4.59 | 5.36 | 8.64 | 0.29 | 0.21 | 0.31 | 0.61 | 1.30 | n/m |
| EPS (₹) | 14.15 | 15.49 | 8.21 | — | -40.49 | 14.10 | 13.29 | 10.41 | 1.17 | 0.84 | 0.97 | 1.56 | 0.05 | 0.04 | 0.06 | 0.11 | 0.24 | n/m |
